Patent details

Basic Information

Publication number:

EP2553095

PCT Application Number:

PCT/EP/2011/054906

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117132167

PCT Publication Number:

WO/2011/121020

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

A process for purifying vitamin K dependent proteins such as coagulation factor IX

French Title of Invention:

Procédé de purification de protéines dépendantes de la vitamine K telles que le facteur de coagulation IX

German Title of Invention:

Verfahren zur Reinigung von Vitamin-K-abhängigen Proteinen wie dem Blutgerinnungsfaktor IX

SPC Number:

Dates

Filing date:

30/03/2011

Grant date:

12/10/2016

EP Publication Date:

12/10/2016

PCT Publication Date:

06/10/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/02/2013

EP B1 Publication Date:

12/10/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

30/03/2017

Expiration date:

30/03/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

30/03/2011

 

 

Name:

Octapharma AG

Address:

Seidenstrasse 2, 8853 Lachen, Switzerland (CH)

Inventor

1

Name:

GILLJAM Gustav

Address:

Sweden (SE)

2

Name:

WINGE Stefan

Address:

Sweden (SE)

Priority

1

Priority Number:

10158511

Priority Date:

30/03/2010

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

282895 P

Priority Date:

16/04/2010

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 9/64;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages